STATE OF WISCONSIN INVESTMENT BOARD - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,337,115
-42.1%
59,666
+5.0%
0.00%
-33.3%
Q2 2023$2,310,422
-20.1%
56,809
-4.9%
0.01%
-33.3%
Q1 2023$2,892,304
+17.2%
59,709
-7.6%
0.01%
+12.5%
Q4 2022$2,466,851
-25.2%
64,628
-1.6%
0.01%
-20.0%
Q3 2022$3,297,000
+19.3%
65,674
-4.8%
0.01%
+42.9%
Q2 2022$2,764,000
-18.2%
68,998
-23.8%
0.01%0.0%
Q1 2022$3,380,000
-6.3%
90,6000.0%0.01%0.0%
Q4 2021$3,609,000
+7.1%
90,6000.0%0.01%0.0%
Q3 2021$3,371,000
-4.2%
90,600
+8.9%
0.01%0.0%
Q2 2021$3,517,000
-10.7%
83,2000.0%0.01%
-12.5%
Q1 2021$3,940,000
-26.8%
83,200
-5.7%
0.01%
-33.3%
Q4 2020$5,383,000
+16.1%
88,200
-11.1%
0.01%0.0%
Q3 2020$4,638,000
-7.8%
99,2000.0%0.01%
-14.3%
Q2 2020$5,033,000
+17.9%
99,200
+3.7%
0.01%0.0%
Q1 2020$4,269,000
+3.7%
95,700
+11.7%
0.01%
+40.0%
Q4 2019$4,116,000
+42.0%
85,7000.0%0.01%
+25.0%
Q3 2019$2,898,000
-13.9%
85,700
+14.6%
0.01%
-11.1%
Q2 2019$3,366,000
+44.0%
74,800
+20.5%
0.01%
+28.6%
Q1 2019$2,337,000
+46.8%
62,100
+33.8%
0.01%
+40.0%
Q4 2018$1,592,000
-26.5%
46,400
+0.7%
0.01%
-16.7%
Q3 2018$2,167,000
+39.4%
46,1000.0%0.01%
+50.0%
Q2 2018$1,555,000
+42.3%
46,100
+14.1%
0.00%
+33.3%
Q1 2018$1,093,000
+173.2%
40,400
+68.3%
0.00%
+200.0%
Q4 2017$400,000
-16.7%
24,0000.0%0.00%0.0%
Q3 2017$480,000
+9.1%
24,0000.0%0.00%0.0%
Q2 2017$440,00024,0000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders